Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: Discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one
Robert Hughes(Scripps Research Institute), Ying Yu(Wuhan University), Jerry W. Cubbage(Pfizer (United States)), Alan MacInnes(Pfizer (United States)), Todd M. Maddux(Pfizer (United States)), Yi Zheng(Pfizer (United States)), Mike B. Tollefson(Pfizer (United States)), Dafydd R. Owen(Pfizer (United States)), E. Jon Jacobsen(Pfizer (United States)), D. Joseph Rogier(Pfizer (United States)), John K. Walker(Pfizer (United States)), Yvette M. Fobian(Pfizer (United States)), Rhadika M. Blevis-Bal(Pfizer (United States)), Brent V. Mischke(Pfizer (United States)), Steve E. Heasley(Pfizer (United States)), Brad A. Acker(Pfizer (United States)), Joseph B. Moon(Pfizer (United States)), David Brown(Unknown), John M. Molyneaux(Pfizer (United States)), Jeanne M. Rumsey(Pfizer (United States)), John N. Freskos(Pfizer (United States)), Brian R. Bond(Pfizer (United States)), Alan G. Benson(Pfizer (United States))
Cited by 15
Related Papers
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
|Neuron|2021|339
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
|Development|2005|301
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
|Bioorganic & Medicinal Chemistry Letters|2009|269